PT-141 Certificate of Analysis (COA) Standards
For analytical and preclinical investigators, evaluating a verifiable PT-141 COA is essential prior to initiating in vitro or in vivo experimental workflows. A comprehensive Certificate of Analysis documents lot-specific chemical identity, purity, moisture content, and endotoxin thresholds to ensure consistent assay reproducibility. PX1 Research provides batch-specific, third-party verified documentation generated in ISO 17025 accredited analytical facilities.
Quick answer
For analytical and preclinical investigators, evaluating a verifiable PT-141 COA is essential prior to initiating in vitro or in vivo experimental workflows. A comprehensive Certificate of Analysis documents lot-specific chemical identity, purity, moisture content, and endotoxin thresholds to ensure consistent assay reproducibility. PX1 Research provides batch-specific, third-party verified documentation generated in ISO 17025 accredited analytical facilities.
Key takeaways
- [PT-141](/research-peptides/pt-141), chemically designated as Bremelanotide, is a synthetic cyclic heptapeptide analog of naturally occurring alpha-melanocyte-stimulating hormone (alpha-MSH).
- A [Certificate of Analysis](/research-peptides/what-is-a-coa-for-peptides) serves as the definitive analytical record for a given chemical synthesis batch.
- Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold-standard method for determining the chromatographic purity of synthetic peptides.
- While HPLC quantifies total sample purity, Mass Spectrometry (MS) verifies the absolute molecular identity of the compound.
Understanding PT-141 (Bremelanotide) in Preclinical Research
PT-141, chemically designated as Bremelanotide, is a synthetic cyclic heptapeptide analog of naturally occurring alpha-melanocyte-stimulating hormone (alpha-MSH). Structure-activity relationship studies indicate that its rigid cyclic structure—formed via a lactam bridge between side-chain carboxyl and amino groups—confers heightened enzymatic stability compared to linear peptide precursors. As a synthetic melanocortin agonist, PT-141 exhibits primary binding affinity toward the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors located within central nervous system pathways.
In preclinical animal models, researchers investigate PT-141 for its central melanocortin-receptor signaling pathways, particularly those governing neuroendocrine responses, energy homeostasis, and central pathways linked to sexual health. Unlike peripherally active vasoactive compounds, PT-141 acts directly upon the hypothalamus to stimulate neurochemical cascades. To maintain experimental control and prevent confounding variables in neurochemical assays, researchers require high-purity material backed by an exhaustive pt-141 coa.
Anatomy of a Legitimate PT-141 Certificate of Analysis
A Certificate of Analysis serves as the definitive analytical record for a given chemical synthesis batch. For laboratory-grade peptides, a robust COA must originate from an independent, ISO 17025 accredited testing facility rather than an in-house manufacturer sheet. This documentation ensures that the primary active ingredient matches its theoretical profile and is free from toxic synthesis byproducts or biological contaminants.
A standard, audit-ready COA for research peptides includes explicit quantitative parameters: high-performance liquid chromatography (HPLC) chromatograms, mass spectrometry (MS) spectra, bacterial endotoxin quantification, Karl Fischer residual moisture measurement, and visual cake appearance inspection. Researchers evaluating high-throughput data depend on these metrics to verify that variance in experimental results stems from physiological mechanisms rather than compound impurity.
HPLC Purity Analysis and Peak Integration
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) is the gold-standard method for determining the chromatographic purity of synthetic peptides. During HPLC analysis, a sample of PT-141 is eluted through a non-polar stationary phase using an aqueous-organic gradient containing ion-pairing agents such as trifluoroacetic acid (TFA). Detectors set at 214 nm or 220 nm monitor the peptide bond absorbance as components exit the column.
The resulting HPLC chromatogram displays the main analyte peak alongside any secondary peaks representing synthesis impurities, such as truncated sequences, deleted amino acids, or diastereomers. Chromatographic purity is calculated by integrating the area under the target peak relative to the total peak area. PX1 Research enforces a strict threshold where every lot must demonstrate exceptional purity via RP-HPLC, documented directly on the product's official analytical report.
Mass Spectrometry (MS) for Identity Confirmation
While HPLC quantifies total sample purity, Mass Spectrometry (MS) verifies the absolute molecular identity of the compound. For PT-141, which possesses a theoretical molecular weight of approximately 1024.18 g/mol, MS analysis ensures that the synthesized sequence matches the exact target molecular mass.
Using Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF), the laboratory measures the mass-to-charge ratio (m/z) of the ionized peptide. A valid peptide purity certificate includes the observed mass spectrum overlaying the expected theoretical mass. The absence of unexpected high-mass adducts or low-mass cleavage fragments confirms that the cyclic lactam structure was successfully formed during chemical synthesis.
Endotoxin Testing: Protecting Cell and Animal Models
Bacterial endotoxins—lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria—are potent pyrogens that can severely disrupt preclinical investigations. In cell culture models, minute endotoxin contamination can trigger inflammatory cytokine cascades, leading to altered cellular expression and cell death. In rodent models, systemic endotoxins cause fever, septic shock, and altered neurochemical signaling, completely invalidating behavioral or pharmacological assays.
PX1 Research subjects every lot of PT-141 to rigorous Limulus Amebocyte Lysate (LAL) testing or recombinant Factor C assays to quantify endotoxin levels in Endotoxin Units per milligram (EU/mg). Maintaining endotoxin levels well below strict research thresholds ensures that observed physiological responses are solely attributable to target melanocortin receptor activation.
Moisture Content and Physical Appearance Verification
Lyophilization, or freeze-drying, is the standard method for preserving peptide stability post-synthesis. A valid COA must specify both the physical appearance of the lyophilized cake and the residual moisture content determined via Karl Fischer titration or Loss on Drying (LOD).
Excess moisture within a peptide vial accelerates hydrolysis reactions, leading to peptide bond cleavage and rapid degradation during storage. A dense, white, homogeneous cake with minimal residual moisture ensures maximum long-term stability when stored at recommended sub-zero temperatures. For full protocol details on peptide physical characteristics, explore our guide on lyophilization and moisture content.
Comparative Analysis: PT-141 and Related Melanocortin Compounds
When designing comparative pharmacological studies, researchers frequently evaluate PT-141 alongside other synthetic melanocortin receptor ligands. Understanding the structural differences and purity requirements across these analogs is vital for selecting the appropriate tool compound.
For instance, Melanotan II shares a non-selective melanocortin receptor agonist profile, engaging MC1R, MC3R, MC4R, and MC5R, whereas PT-141 is a metabolite derivative designed with decreased binding affinity for MC1R while retaining potency at central MC3R and MC4R sites. Another related compound, Setmelanotide, demonstrates high selectivity for MC4R and is primarily investigated for metabolic pathways and obesity signaling models. Evaluating individual lot COAs across these related peptides ensures that receptor cross-reactivity and synthesis-related impurities do not skew comparative signaling data.
ISO 17025 Laboratory Auditing and Traceability
Not all COAs carry equal scientific weight. A document produced by an unaccredited manufacturer without verifiable laboratory credentials lacks the chain-of-custody protocols required for high-impact research. PX1 Research partners exclusively with independent, third-party laboratories operating under ISO/IEC 17025 accreditation.
ISO 17025 accreditation mandates strict equipment calibration, validated analytical methodologies, and independent oversight. Each COA provided by PX1 includes lot-specific tracking numbers and direct laboratory contact information, allowing academic institutions and private biotechnology facilities to independently audit test results.
Handling, Storage, and Reconstitution in Laboratory Settings
To preserve the chemical integrity validated by the COA, researchers must follow strict laboratory handling guidelines upon receiving lyophilized PT-141. Vials should be stored at -20°C or -80°C in a desiccated environment to prevent atmospheric moisture absorption.
Prior to reconstitution, vials must be allowed to equilibrate to room temperature to prevent condensation within the container. Reconstitution should be performed under a laminar flow hood using sterile, laboratory-grade bacteriostatic water or target-buffered solutions. Repeated freeze-thaw cycles must be avoided, as ice crystal formation can disrupt the peptide's secondary structure and alter binding kinetics in downstream assays. For institutional purchasing and volume requirements, visit our wholesale research portal.
PX1 Research Standards for Research Compounds
PX1 Research is dedicated to supplying high-grade, USA-synthesized research peptides to the scientific community. Every compound—including PT-141—is manufactured in GMP-compliant facilities and thoroughly tested across multi-step analytical panels before release.
To support rigorous experimental timelines, PX1 Research provides same-day shipping Monday through Friday for all orders, dispatching directly from specialized distribution centers in California and Arizona. By combining transparent, batch-specific COAs with consistent synthesis protocols, PX1 serves as a trusted partner for university laboratories, contract research organizations, and biotechnology institutions. Access full analytical reports and documentation via our comprehensive research hub.
Frequently Asked Questions
What primary metrics should I inspect on a PT-141 COA?
A valid PT-141 COA must display lot-specific HPLC chromatographic purity (typically ≥98%), ESI-MS or MALDI-TOF mass spectra confirming the molecular mass (~1024.18 g/mol), bacterial endotoxin limits (in EU/mg), residual moisture analysis, and confirmation of physical cake appearance.
Why is endotoxin testing critical for PT-141 research?
Endotoxins (lipopolysaccharides) induce non-specific inflammatory responses and cytokine release in both in vitro cell cultures and in vivo animal models. Verifying low endotoxin levels on the COA prevents pyrogenic interference with melanocortin receptor signaling assays.
How does PX1 Research verify the purity of its PT-141 lots?
PX1 Research utilizes independent, ISO 17025 accredited third-party laboratories to conduct reversed-phase HPLC (RP-HPLC) and mass spectrometry (MS) analysis on every production batch.
Is PT-141 provided by PX1 Research intended for clinical use?
No. All products offered by PX1 Research, including PT-141, are strictly synthesized for laboratory research use only (in vitro and preclinical animal models) and are not intended for human or veterinary administration.
What is the theoretical molecular weight of PT-141 verified on the mass spec?
The theoretical molecular weight of PT-141 (Bremelanotide acetate) is approximately 1024.18 g/mol. Mass spectrometry results on the COA should align precisely with this observed mass.
How should lyophilized PT-141 be stored once delivered?
Lyophilized PT-141 should be stored at -20°C or lower upon receipt, protected from light and moisture. Once reconstituted with a sterile solvent, solutions should be aliquoted and kept refrigerated or frozen to avoid freeze-thaw cycles.
Where does PX1 Research ship its research compounds from?
PX1 Research ships all orders directly from facilities located in California and Arizona, offering same-day dispatch for orders placed Monday through Friday.
Can I obtain the exact batch-specific COA prior to placing an institutional order?
Yes, PX1 Research provides batch-specific Certificates of Analysis for all active lots. Contact our laboratory customer support or access product listings to review current batch documentation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.